Cygnal Therapeutics
325 Vassar Street, Suite 2B
Cambridge, MA 02139
United States
Tel: (877) 441-4374
Email: info@cygnaltx.com
About Cygnal Therapeutics
Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology.
From cancer to gut inflammation and other areas of disease, nerves function in ways far beyond canonical contexts and mechanisms. The tissues they permeate make use of biochemical neural pathways and signals, and many non-neuronal cells communicate with and mimic nerves in disease settings. This is a novel way of thinking about neural signaling as outside—or exo—traditional neurobiology.
Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platform™, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.
5 jobs with Cygnal Therapeutics
-
Associate Computational Biologist
Cygnal, a new biology platform company, was founded by Flagship Pioneering to pioneer the field of exoneural biology – the impact of the peripheral n
New
-
Executive Director/Sr. Director, GI/Inflammation Diseases
The Company Cygnal Therapeutics is a privately held, early-stage biotechnology company pioneering the field of Exoneural Biology – the neural regulati
-
Senior/Executive Director – Immune-Oncology and Oncology
Cygnal, a new biology platform company, was founded by Flagship Pioneering to pioneer the field of exoneural biology – the impact of the peripheral n
-
Associate Scientist, Immunology
Cygnal, a new biology platform company, was founded by Flagship Pioneering to pioneer the field of exoneural biology – the impact of the peripheral n
-
Senior/Executive Director, Human Resources
Cygnal, a new biology platform company, was founded by Flagship Pioneering to pioneer the field of exoneural biology – the impact of the peripheral n